The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Rheumatoid Arthritis — Cutaneous Manifestations

Skin findings of rheumatoid arthritis including rheumatoid nodules, vasculitis, neutrophilic dermatoses, and drug-related eruptions, often signaling disease activity and severity.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Rheumatoid Arthritis — Cutaneous Manifestations?

Rheumatoid arthritis is a systemic autoimmune disease primarily affecting synovial joints, but extra-articular involvement, especially cutaneous, reflects disease activity, severity, and the presence of rheumatoid factor or anti-CCP antibodies. Cutaneous findings span from common (rheumatoid nodules in 20–30%) to rare neutrophilic and granulomatous dermatoses.

Pathogenesis varies by manifestation: nodules involve perivascular T-cell infiltration with central fibrinoid necrosis surrounded by palisading histiocytes; rheumatoid vasculitis is immune-complex mediated affecting small and medium vessels; neutrophilic dermatoses share with paradoxical biologic reactions a Th17/IL-17 axis activation.

Drug-induced cutaneous reactions to RA therapy include methotrexate-induced photosensitivity, hydroxychloroquine pigmentation, sulfasalazine eruption, anti-TNF-induced psoriasis, lupus-like syndrome, and TNF-paradoxical pyoderma gangrenosum or hidradenitis suppurativa flares.

Symptoms

Rheumatoid nodules: firm, mobile, subcutaneous nodules over extensor surfaces (elbows, knuckles, occiput), 0.5–5 cm, sometimes painful or ulcerated
Rheumatoid vasculitis: palpable purpura, livedo reticularis, digital ulcers, gangrene, mononeuritis multiplex
Pyoderma gangrenosum: rapidly enlarging painful ulcer with violaceous undermined border on lower extremities
Sweet syndrome (acute febrile neutrophilic dermatosis): tender erythematous plaques with fever, often during disease flare
Interstitial granulomatous dermatitis: linear erythematous cords ("rope sign") on lateral trunk
Palmar erythema (active disease)
Bywaters lesions: tiny digital infarcts on fingertips and nail folds
Drug-related eruptions: photosensitivity, urticaria, fixed drug eruption, paradoxical psoriasis (anti-TNF), lichenoid reaction (hydroxychloroquine)

Risk Factors

Long-standing seropositive RA (rheumatoid factor, anti-CCP)
Active disease with high CRP and elevated DAS28
Smoking (vasculitis and nodulosis risk)
Methotrexate-induced accelerated nodulosis
Concurrent biologic therapy (TNF inhibitors, JAK inhibitors)
Vasculopathy comorbidity
Chronic ulcers from concomitant venous insufficiency or pressure

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New tender ulcer with violaceous border — pyoderma gangrenosum suspicion, urgent rheumatology and dermatology
  • Painful palpable purpura, digital ischemia, mononeuritis multiplex — rheumatoid vasculitis emergency
  • Sudden tender plaques with fever — Sweet syndrome workup
  • Worsening rheumatoid nodules with ulceration
  • Drug-related skin reaction during DMARD/biologic therapy

Treatment Methods

01
Disease control is paramount: optimize RA therapy with methotrexate, JAK inhibitors (tofacitinib, baricitinib, upadacitinib), or biologics (anti-TNF, anti-IL-6, abatacept, rituximab) based on activity and manifestation
02
Rheumatoid nodules: most regress with effective DMARD therapy; intralesional triamcinolone injection for persistent or painful nodules; surgical excision for ulcerated, infected, or mechanically problematic lesions; methotrexate-induced accelerated nodulosis may require switching to alternative DMARD
03
Rheumatoid vasculitis: high-dose corticosteroids (prednisolone 1 mg/kg, IV pulse methylprednisolone for severe), cyclophosphamide or rituximab for organ-threatening disease, anti-TNF or abatacept for refractory cases
04
Pyoderma gangrenosum: high-potency topical and intralesional corticosteroids, systemic corticosteroids, cyclosporine, anti-TNF (infliximab, adalimumab), IL-1 inhibitors (anakinra, canakinumab), anti-IL-23 (guselkumab); avoid surgical debridement which triggers pathergy
05
Sweet syndrome: oral prednisolone with rapid taper, dapsone, colchicine, potassium iodide; treat underlying flare
06
Interstitial granulomatous dermatitis: topical or systemic corticosteroids, methotrexate, hydroxychloroquine; resolves with disease control
07
Adverse drug reactions: identify offending agent, discontinue or switch class, manage with topical corticosteroids and antihistamines; rechallenge with caution
08
Wound care for ulcerated nodules and vasculitis: gentle debridement (avoid in PG), advanced dressings (hydrocolloid, alginate), compression for venous comorbidity, infection control
09
Lifestyle: smoking cessation (improves vasculitis and overall RA outcomes), photoprotection on methotrexate, sun avoidance with hydroxychloroquine
10
Multidisciplinary: rheumatology, dermatology, vascular surgery, plastic surgery for complex ulcers and limb-threatening disease

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.